Circulating Tumor Cells Patent Landscape and Forecast 2024-2032 - The U.S. Leads with Over 4,000 Patent Filings, Driven by Robust R&D Infrastructure and Substantial Investments in Cancer Diagnostics Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032" has been added to ResearchAndMarkets.com's offering.The circulating tumor...

U.S. Liquid Biopsy Market Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031 Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application, End User, Clinical...

Circulating Tumor Cell (CTC) Market Forecast to Reach $26.1 Billion by 2032: Key Global and Regional Insights by Technology, Application, Product, Specimen, and End User Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032" report has been added to ...

United States Liquid Biopsy Market Analysis Report 2024: A $3.68 Billion Industry by 2032 from $1.06 Billion in 2023 - Emphasis on Companion Diagnostics, Increasing acceptance of Non-invasive Techniques Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market Report by Cancer types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032"...

Global Circulating Tumor Cells Market Projected to Reach USD 27.55 Billion by 2030, Driving Advancements in Cancer Management Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Global Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone...